#IDMastodon #cancercare Annual #covid19vaccine boosting for patients undergoing #antineoplasticcancer treatments reduced risks for targeted or hormonal treatments, immunotherapy, and chemotherapy-immunotherapy combinations similarly to the general population. Patients receiving no treatment or #chemotherapy exhibited higher risks, suggesting that accelerated vaccination schedules should be considered. Patients treated with #rituximab therapy posed the highest infection risk .

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

Im Januar und Februar bekam ich das letzte Mal Rituximab als Infusion. Seitdem komme ich mit 4 mg Cortison und 100 mg Azathioprin gut über die Runden.
Die letzten Monate haben mir so gut getan, ich hatte nur wenig Schmerzen. Mein Laufen ist durch die kaputten Knie und das Sprunggelenk schon noch eingeschränkt, in den Knien gibt es auch häufiger Schwellungen.
#Rituximab #wieesist #Lupus #chronischkrank #tagebuchbloggen #RA

https://www.lupus-live.de/?p=11255

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history

💊💉 #rituximab
SmPC for Rixathon 500 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 4.8 Undesirable effects; 4.9 Overdose; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/10322/smpc
Change log: https://www.medicines.org.uk/emc/product/10322/smpc/history

💊💉 #rituximab
SmPC for Rixathon 100 mg concentrate for solution for infusion has been updated with changes to sections 4.2 Posology and method of administration; 10. Date of revision of the text on 21st June 2023.
🌐 https://www.medicines.org.uk/emc/product/2714/smpc
Change log: https://www.medicines.org.uk/emc/product/2714/smpc/history